These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2892540

  • 1. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
    Giral P, Martin P, Soubrié P, Simon P.
    Biol Psychiatry; 1988 Feb 01; 23(3):237-42. PubMed ID: 2892540
    [Abstract] [Full Text] [Related]

  • 2. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
    Martin P, Beninger RJ, Hamon M, Puech AJ.
    Behav Brain Res; 1990 May 07; 38(2):135-44. PubMed ID: 2141988
    [Abstract] [Full Text] [Related]

  • 3. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
    Martin P.
    Psychopharmacology (Berl); 1991 May 07; 104(2):275-8. PubMed ID: 1678895
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F, Dourish CT, Brazell C, McClue S, Stahl SM.
    Psychoneuroendocrinology; 1988 May 07; 13(6):471-8. PubMed ID: 2907164
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm.
    Martin P, Tissier MH, Adrien J, Puech AJ.
    Life Sci; 1991 May 07; 48(26):2505-11. PubMed ID: 1828519
    [Abstract] [Full Text] [Related]

  • 8. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E, Goldstein M, Bohmaker K.
    Mol Pharmacol; 1990 Feb 07; 37(2):231-7. PubMed ID: 1968223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 11. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
    Barrett JE, Fleck-Kandath C, Mansbach RS.
    Pharmacol Biochem Behav; 1988 Jul 06; 30(3):723-7. PubMed ID: 2905470
    [Abstract] [Full Text] [Related]

  • 12. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD, Wright RN, Margraf RR, Eison AS.
    Pharmacol Biochem Behav; 1990 Jan 06; 35(1):251-4. PubMed ID: 2138331
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
    Mansbach RS, Geyer MA.
    Eur J Pharmacol; 1988 Nov 08; 156(3):375-83. PubMed ID: 2975225
    [Abstract] [Full Text] [Related]

  • 16. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R, De Vry J.
    Eur J Pharmacol; 1993 Nov 16; 249(3):341-51. PubMed ID: 7904566
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.
    Kennett GA, Dourish CT, Curzon G.
    Eur J Pharmacol; 1987 Feb 24; 134(3):265-74. PubMed ID: 2883013
    [Abstract] [Full Text] [Related]

  • 19. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
    Peroutka SJ, Mauk MD, Kocsis JD.
    Neuropharmacology; 1987 Feb 24; 26(2-3):139-46. PubMed ID: 2884586
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.